PEN vs SGEN
Penumbra Inc (PEN) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Penumbra Inc (PEN) is a medical devices company listed on US.
SGEN (SGEN) common stock.
Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
SGEN does not have a complete income-statement cache yet.
PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Not investment advice. Open the PEN and SGEN stock pages for the full models.
Not investment advice.